| NLRP3 monomer Functional Dynamics: from the Effects of Allosteric Binding to Implications for Drug Design | Sep 7, 2023 | Drug Design | —Unverified | 0 |
| Old Drugs for Newly Emerging Viral Disease, COVID-19: Bioinformatic Prospective | Mar 10, 2020 | Drug Design | —Unverified | 0 |
| One-way Explainability Isn't The Message | May 5, 2022 | Drug Design | —Unverified | 0 |
| Optimization of Tree Ensembles | May 30, 2017 | Drug Design | —Unverified | 0 |
| Optimized Drug Design using Multi-Objective Evolutionary Algorithms with SELFIES | May 1, 2024 | Drug DesignEvolutionary Algorithms | —Unverified | 0 |
| Optimizing Drug Design by Merging Generative AI With Active Learning Frameworks | May 4, 2023 | Active LearningDrug Design | —Unverified | 0 |
| Overview of Current Type I/II Kinase Inhibitors | Nov 23, 2018 | Drug DesignVocal Bursts Type Prediction | —Unverified | 0 |
| ParaVS: A Simple, Fast, Efficient and Flexible Graph Neural Network Framework for Structure-Based Virtual Screening | Feb 8, 2021 | Drug DesignGraph Neural Network | —Unverified | 0 |
| PepINVENT: Generative peptide design beyond the natural amino acids | Sep 21, 2024 | Drug Design | —Unverified | 0 |
| Persistent Dirac for molecular representation | Feb 5, 2023 | Drug Designmolecular representation | —Unverified | 0 |
